Massive new registry to track thousands of blood cancer patients for years
NCT ID NCT02863692
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a registry that will follow up to 8,000 people with chronic lymphocytic leukemia (CLL) and related blood cancers over many years. It does not test a new treatment but instead collects information on how patients are doing over time, including survival. The goal is to better understand the long-term course of these diseases and improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
RECRUITINGDresden, Saxony, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Zinc-Based compound fight cancer?
- Lab-Grown lymph node model reveals how CLL cells resist treatment
- Which Pre-CAR-T chemo is safer? new trial aims to find out
- New study checks bleeding risk when CLL drug meets blood thinners
- New drug targets Hard-to-Treat blood cancers in chinese trial
- Engineered cells take on hard-to-treat blood cancers in early trial